Invesaro

Stocks Comparison

Cardiff Lexington vs Hims & Hers Health: revenue, profit, margins and growth compared

Cardiff Lexington brought in $11.5M of revenue in fiscal 2025, Hims & Hers Health $2.3B in fiscal 2025. Revenue changed by +39.5% at Cardiff Lexington and +59.0% at Hims & Hers Health on the year before, so Hims & Hers Health grew faster. Cardiff Lexington kept -47.7% of its revenue as net profit, Hims & Hers Health 5.5%.

Side by side, latest fiscal year

CDIXHIMS
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$11.5M$2.3B
Revenue growth+39.5%+59.0%
Net income-$5.5M$128.4M
Net margin-47.7%5.5%
Free cash flown/a$57.4M
Free cash flow marginn/a2.4%
Earnings per share (diluted)n/a$0.51
Cash$318.5K$228.6M
Debt$18.6Mn/a
Price to earningsn/a56.4
Market value$6.6M$6.7B
Dividend yieldn/an/a
Rank by revenue in sector#508 of 742 · Health care#105 of 742 · Health care

Over the years

Revenue
CDIX FY2018: $2.2MCDIX FY2019: $4.5MCDIX FY2020: $3.5MCDIX FY2021: $9.9MCDIX FY2022: $10.7MCDIX FY2023: $11.9MCDIX FY2024: $8.3MCDIX FY2025: $11.5MHIMS FY2019: $82.6MHIMS FY2020: $148.8MHIMS FY2021: $271.9MHIMS FY2022: $526.9MHIMS FY2023: $872MHIMS FY2024: $1.5BHIMS FY2025: $2.3BFY18FY19FY20FY21FY22FY23FY24FY25
CDIX $11.5MHIMS $2.3B
Net income
CDIX FY2018: -$6.3MCDIX FY2019: -$7.2MCDIX FY2020: -$2.8MCDIX FY2021: $666.3KCDIX FY2022: -$5.4MCDIX FY2023: $3MCDIX FY2024: -$3.3MCDIX FY2025: -$5.5MHIMS FY2019: -$72.1MHIMS FY2020: -$18.1MHIMS FY2021: -$107.7MHIMS FY2022: -$65.7MHIMS FY2023: -$23.5MHIMS FY2024: $126MHIMS FY2025: $128.4MFY18FY19FY20FY21FY22FY23FY24FY25
CDIX -$5.5MHIMS $128.4M
Net margin
CDIX FY2018: -281.3%CDIX FY2019: -158.1%CDIX FY2020: -82.2%CDIX FY2021: 6.7%CDIX FY2022: -50.8%CDIX FY2023: 25.5%CDIX FY2024: -39.9%CDIX FY2025: -47.7%HIMS FY2019: -87.3%HIMS FY2020: -12.2%HIMS FY2021: -39.6%HIMS FY2022: -12.5%HIMS FY2023: -2.7%HIMS FY2024: 8.5%HIMS FY2025: 5.5%FY18FY19FY20FY21FY22FY23FY24FY25
CDIX -47.7%HIMS 5.5%
Revenue growth
CDIX FY2019: +103.9%CDIX FY2020: -24.0%CDIX FY2021: +186.1%CDIX FY2022: +8.2%CDIX FY2023: +10.8%CDIX FY2024: -30.2%CDIX FY2025: +39.5%HIMS FY2020: +80.2%HIMS FY2021: +82.8%HIMS FY2022: +93.8%HIMS FY2023: +65.5%HIMS FY2024: +69.3%HIMS FY2025: +59.0%FY19FY20FY21FY22FY23FY24FY25
CDIX +39.5%HIMS +59.0%
Free cash flow
CDIX FY2018: -$2MCDIX FY2020: -$903.4KCDIX FY2021: -$853.5KCDIX FY2022: -$1.2MHIMS FY2022: -$33.7MHIMS FY2023: $47MHIMS FY2024: $198.3MHIMS FY2025: $57.4MFY18FY20FY21FY22FY23FY24FY25
CDIX -$1.2MHIMS $57.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cardiff Lexington and Hims & Hers Health

Which is bigger by revenue, Cardiff Lexington or Hims & Hers Health?

Hims & Hers Health is bigger by revenue: $2.3B in fiscal 2025, against $11.5M for Cardiff Lexington in fiscal 2025.

Which keeps more of its revenue as profit, Cardiff Lexington or Hims & Hers Health?

Cardiff Lexington had a net margin of -47.7% in fiscal 2025; Hims & Hers Health had 5.5% in fiscal 2025.

Which grew revenue faster, Cardiff Lexington or Hims & Hers Health?

In their latest fiscal years revenue changed by +39.5% at Cardiff Lexington and +59.0% at Hims & Hers Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies